Evidence map›Paper›PMID 28623914›Full record

ArticleJournal of translational medicine2017

Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.

Haruhisa Kitano, Joon-Yong Chung, Kyung Hee Noh, Young-Ho Lee, Tae Woo Kim, Seok Hyung Lee, Soo-Heang Eo, Hyung Jun Cho, Chel Hun Choi, Shuhei Inoue and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Food insecurity promotes adiposity in mice.Obesity (Silver Spring, Md.) · 2025
    Article
  3. Article
  4. Advances in lymphatic metastasis of non-small cell lung cancer.Cell communication and signaling : CCS · 2024
    Review
  5. Review
  6. Article
  7. Tools used to assay genomic instability in cancers and cancer meiomitosis.Journal of cell communication and signaling · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Haruhisa KitanoExperimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Joon-Yong ChungExperimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.ORCID 0000-0001-5041-5982
Kyung Hee NohDepartment of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, 136-701, Korea.
Young-Ho LeeDepartment of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, 136-701, Korea.
Tae Woo KimDepartment of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, 136-701, Korea.
Seok Hyung LeeDepartment of Statistics, Korea University, Seoul, 136-701, Korea.
Soo-Heang EoDepartment of Statistics, Korea University, Seoul, 136-701, Korea.
Hyung Jun ChoDepartment of Statistics, Korea University, Seoul, 136-701, Korea.
Chel Hun ChoiExperimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Shuhei InoueDepartment of Thoracic Surgery, National Hospital Organization Higashi-Ohmi General Medical Center, Higashi-Oumi, 527-8505, Japan.
Jun HanaokaDepartment of Thoracic Surgery, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Junya FukuokaDepartment of Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4, Sakamoto, Nagasaki, 852-8523, Japan. fukuokaj@nagasaki-u.ac.jp.
Stephen M HewittExperimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. genejock@helix.nih.gov.ORCID 0000-0001-8283-1788
National Institutes of Health · USKorea University · KRStatistics Korea · KRNagasaki University · JPNational Hospital Organization · JPShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe interaction of vascular endothelial growth factor-C (VEGF-C)/VEGF-D/VEGF receptor-3 is considered to be a major driver of lymphangiogenesis, however the mechanism of this process remains unclear. We aimed to investigate the possible lymphangiogenic significance of synaptonemal complex protein 3 (SCP3) in non-small cell lung cancer (NSCLC).

methodsThe expression of SCP3, VEGF-C, and VEGF-D were measured and examined a correlation between SCP3 and VEGF-C or VEGF-D in various human lung cancer cell lines. Subsequently, we assessed SCP3, VEGF-A, VEGF-B, VEGF-C, and VEGF-D expression in archival tumor tissues from 89 NSCLC patients with lymph node (LN) metastasis by combined immunohistochemistry with quantitative digital image analysis.

resultsPositive correlations between SCP3 and VEGF-C expression (R

conclusionsSCP3 is associated with lymphangiogenesis and provides insight into the SCP3-VEGF-C/VEGF-D axis based cancer therapy strategy.

Indexed as

LymphangiogenesisAgedCarcinoma, Non-Small-Cell LungCell Cycle ProteinsCell Line, TumorDNA-Binding ProteinsFemaleHumansLung NeoplasmsLymphatic MetastasisMaleMiddle AgedMultivariate AnalysisNuclear ProteinsPrognosisSurvival AnalysisCell Cycle ProteinsDNA-Binding ProteinsNuclear ProteinsSYCP3 protein, humanVascular Endothelial Growth Factor AVascular Endothelial Growth Factor BVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DLymphangiogenesisLymph node metastasisNon-small cell lung cancerSCP3Vascular endothelial growth factor

Identifiers

PMID28623914
PMCPMC5473978
OpenAlexW2626106445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.